In July 2024, the Lancet Commission on Dementia Prevention published its most recent update, and for the first time it added untreated vision loss to its list of modifiable dementia risk factors. That addition got considerably less attention than it deserved, in part because vision is not something most people associate with brain health.
The evidence behind the decision is substantial, and the practical implications are unusually clear. Unlike many dementia risk factors, vision loss is often straightforward and inexpensive to treat.
What the Lancet Commission Found
The Commission reviews the global evidence on dementia risk and periodically updates its list of factors that, if addressed, could prevent or delay a meaningful share of cases. The 2020 report identified 12 modifiable factors. The 2024 update added two more: high LDL cholesterol and untreated vision loss, bringing the total to 14 factors that together account for roughly 45% of global dementia cases.
The evidence the Commission cited for vision loss was considerable. It included a meta-analysis of 14 prospective cohort studies with follow-up ranging from 3.7 to 14.5 years, covering more than 6.2 million older adults who were cognitively intact at baseline, of whom nearly 172,000 went on to develop dementia. Vision loss was associated with a pooled relative risk for dementia of 1.47.
The Commission estimated that addressing vision problems in late life could reduce dementia cases globally by approximately 2%. That sounds small until you consider the scale: dementia affects roughly 57 million people worldwide with nearly 10 million new cases annually, making 2% a substantial number of preventable cases.
A separate 2024 analysis published in JAMA Ophthalmology estimated that somewhere between 5% and 19% of prevalent dementia among U.S. adults aged 71 and older could be statistically attributable to one or more measurable vision impairments, with reduced contrast sensitivity appearing particularly significant.
Not All Eye Conditions Carry the Same Risk
The research indicates that different eye conditions are associated with different levels of dementia risk.
Cataracts are associated with roughly a 17% increased dementia risk. Diabetic retinopathy, a complication of diabetes affecting the blood vessels of the retina, is associated with approximately a 34% increased risk. Research from the Adult Changes in Thought study, led by Dr. Cecilia Lee and colleagues and cited directly in the Lancet report, found that diabetic retinopathy appears to function as an important biomarker of dementia risk in people with type 2 diabetes.
That distinction matters for interpretation. Diabetic retinopathy may signal underlying microvascular disease affecting both the retina and the brain, meaning the eye finding reflects a shared disease process rather than causing cognitive decline directly. Cataract, by contrast, is a mechanical clouding of the lens with no direct connection to brain pathology, which makes it a cleaner test of whether vision loss itself matters.
The Cataract Surgery Evidence
The strongest and most practically useful evidence comes from studies of cataract surgery.
A study published in JAMA Internal Medicine in 2022 by Lee and colleagues, drawing on the Adult Changes in Thought cohort, examined dementia outcomes after cataract extraction. This study was a key piece of evidence in the Lancet Commission’s decision, and it found that cataract surgery was associated with reduced dementia risk.
A systematic review and meta-analysis including 24 published studies with a total of 558,276 participants examined the effect of cataract surgery on cognitive outcomes more broadly. A UK Biobank analysis of 300,823 people found that people with cataracts were at increased dementia risk, and that there was no difference in dementia risk between participants who underwent cataract surgery and healthy controls. In other words, the surgery appeared to bring risk back toward baseline.
This is an unusual finding in dementia prevention research. Most modifiable risk factors involve sustained behavior change over years with modest effect sizes. Cataract surgery is a single outpatient procedure, widely available, generally covered by insurance, and among the most commonly performed surgeries in the world.
Why Vision Loss Might Affect the Brain
Researchers have proposed several mechanisms, and the Lancet Commission itself raised the question of whether the association reflects the vision loss, the underlying illness causing it, or shared pathology between the retina and the brain.
Reduced sensory input. The brain requires stimulation to maintain function. When visual input degrades, the regions that process it receive less activation, and there is evidence of accelerated atrophy in visual processing areas in people with vision loss.
Cognitive load. Like hearing loss, impaired vision forces the brain to work harder to interpret ambiguous input. Resources diverted to basic perception are unavailable for memory, reasoning, and other functions.
Social isolation and reduced activity. People who cannot see well stop driving, stop reading, withdraw from social settings, and become less physically active. Each of those is independently associated with dementia risk. This indirect pathway may account for a substantial share of the association.
Shared vascular pathology. The retina is, developmentally, an extension of the brain, and it shares similar microvasculature. Conditions that damage small blood vessels in the retina, particularly diabetes and hypertension, damage them in the brain as well. Some of the association almost certainly reflects this shared underlying disease rather than a causal effect of vision loss itself.
Increased fall risk. Vision impairment raises the risk of falls, and falls are the leading cause of traumatic brain injury in older adults, which is itself a dementia risk factor.
What Makes This Actionable
The Lancet Commission noted something important: treatment for visual loss is effective and cost-effective for an estimated 90% of people, yet visual loss frequently goes untreated, particularly in lower and middle income countries.
That gap between treatability and treatment is what makes vision one of the more promising targets on the risk factor list. Most people with cataracts, refractive error, or correctable vision problems can have them addressed. The barriers are usually access, cost, awareness, or simple inertia rather than the absence of effective treatment.
Practical steps that follow from this research include regular comprehensive eye examinations, particularly after age 60, when cataracts, glaucoma, and macular degeneration become common. Vision changes develop gradually enough that people routinely underestimate their own impairment. Diabetic patients should be receiving annual dilated retinal exams, both for eye health and, based on this research, as a potential marker of broader risk. And a cataract diagnosis is worth addressing rather than deferring indefinitely, which many people do because the vision loss progresses slowly enough to adapt to.
For People Who Already Have Dementia
Vision impairment in someone with dementia compounds the problem substantially. A person who cannot see well and cannot process what they see well is operating at a severe disadvantage, and the result is often increased confusion, agitation, and fall risk.
Correcting vision does not treat the dementia, but it removes an obstacle. Ensuring that glasses are current and actually being worn, that lighting is adequate, that contrast is used effectively in the environment, and that any treatable eye condition has been addressed are all reasonable steps that can meaningfully improve daily functioning.
It is also worth knowing that vision problems in people with dementia are frequently missed, because difficulties with perception and recognition get attributed entirely to the cognitive impairment. Confirming that someone can actually see before concluding they cannot recognize something is a basic and often skipped step.
An Honest Caveat
The Lancet Commission itself flagged the interpretive difficulty. The association between vision loss and dementia is consistent across studies, but disentangling causation from shared underlying pathology and reverse causation remains difficult. Early dementia can itself cause visual processing problems, which complicates the temporal picture.
The cataract surgery evidence is the strongest argument that vision loss matters causally, because cataract is mechanically unrelated to brain pathology and its correction appears to normalize risk. But the overall picture is still developing, and the Commission’s estimate of a 2% population attributable fraction reflects appropriate caution rather than certainty.
What is not in question is that treating vision loss improves quality of life, independence, safety, and social engagement, all of which are worth pursuing regardless of the cognitive question.
Vision loss and hearing loss appear to affect dementia risk through overlapping pathways, including sensory deprivation and social withdrawal. Our post on the link between hearing loss and dementia covers that evidence in detail, including results from the ACHIEVE randomized trial.
Have questions about memory care for a loved one?
We are happy to talk. Whether you are just starting to research your options or are further along in the process, reach out anytime.
463-444-9064 | Ben@HonorHavenSeniorLiving.com | Schedule a Tour
Sources
- Livingston G, Huntley J, Liu KY, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. The Lancet. 2024;404(10452):572-628.
- Lee CS, Gibbons LE, Lee AY, et al. Association Between Cataract Extraction and Development of Dementia. JAMA Internal Medicine. 2022;182(2):134-141.
- Shang X, Zhu Z, Wang W, Ha J, He M. The Association between Vision Impairment and Incidence of Dementia and Cognitive Impairment: A Systematic Review and Meta-analysis. Ophthalmology. 2021;128(8):1135-1149.
- Smith JR, Huang AR, et al. Prevalence of Dementia Attributable to Vision Impairment Among Older US Adults. JAMA Ophthalmology. 2024.
- Yeo BSY, Ong RYX, Ganasekar P, Tan BKJ, Seow DCC, Tsai ASH. Association of Cataract Surgery With Cognitive Impairment and Dementia: A Systematic Review and Meta-analysis. 2025.
- Alzheimer’s Association. 2025 Alzheimer’s Disease Facts and Figures. Alzheimer’s & Dementia. 2025.